Environment, Pathogens, and Host Interactions in Melioidosis
Starting soon
Conditions studied: Melioidosis
In brief
This is a longitudinal, multicentre observational study conducted across three established microbiology units integrated within hospital and community health systems in Thailand, Lao PDR, and Cambodia. The hospital cohort will enroll approximately1,000 patients with positive melioidosis. Participants will be followed at six time points from admission through one year (post-discharge) to capture acute and recovery-phase outcomes, with clinical data collected on demographics, comorbidities, exposures, treatment, adherence, and outcomes. For each confirmed case, a healthy control will be recruited within two weeks and matched by age, sex, and village of residence. Controls with no symptoms or history of melioidosis will provide a single blood sample at enrolment and will be followed by telephone at 6 and 12 months. In addition to hospital-based surveillance, a high-risk community in northern Ubon Ratchathani-referred to as the Sandbox Village-will be intensively monitored to capture subclinical infections and to assess environmental factors influencing disease acquisition. This study is funded by the Wellcome Trust. The grant reference number is 323077/Z/24/Z
Key facts
- Study ID
- NCT07345910
- Run by
- University of Oxford
- People needed
- 2400
- Starts
- 2026-08-01
- Expected to finish
- 2034-12-01
- Last updated by the study team
- 2026-08-10
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Cambodia-Oxford Medical Research Unit (COMRU) — Siem Reap, Cambodia
- Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU) — Vientiane, Laos
- Sunpasitthiprosong Hospital — Ubon Ratchathani, Thailand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.